Clearance of Amyloid-#946; Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease

E-ISSN： 1996-3181|8|1|16-30

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.8, Iss.1, 2009-03, pp. : 16-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of the Cell Surface LRP and Soluble LRP in Blood-Brain Barrier A#946; Clearance in Alzheimers Disease

Current Pharmaceutical Design, Vol. 14, Iss. 16, 2008-06 ,pp. : 1601-1605

Bentham Science Publishers

Access to resources Recommend Favorite

Circulating amyloid- peptide crosses the blood-brain barrier in aged monkeys and contributes to Alzheimer's disease lesions

By Mackic J.B. Bading J. Ghiso J. Walker L. Wisniewski T. Frangione B. Zlokovic B.V.

General Pharmacology, Vol. 38, Iss. 6, 2002-06 ,pp. : 303-313

Elsevier

Access to resources Recommend Favorite

The Role of the ATP-Binding Cassette Transporter P-Glycoprotein in the Transport of &bgr;-Amyloid Across the Blood-Brain Barrier

Current Pharmaceutical Design, Vol. 17, Iss. 26, 2011-09 ,pp. : 2778-2786

Bentham Science Publishers

Access to resources Recommend Favorite

Polypeptide Delivery Across The Blood-Brain Barrier

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 2, 2004-04 ,pp. : 131-136

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Delivery Across the Blood-Brain Barrier

Current Drug Delivery, Vol. 1, Iss. 4, 2004-10 ,pp. : 361-376

Bentham Science Publishers

Access to resources Recommend Favorite